News & Resources

Current and relevant information for our customers.

Upcoming Events

ASHP Midyear / December 4-8, 2022
Connect with us in Las Vegas at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition.
Set up a time to meet

SABCS Symposium / December 6-10, 2022
Join us in San Antonio for the San Antonio Breast Cancer Symposium.
Set up a time to meet

ASH Annual Meeting / December 10-13, 2022
Connect with us in New Orleans at the American Society of Hematology (ASH) Annual Meeting & Exhibition.
Set up a time to meet

Resources

Did you know that biosimilar medicines are providing essential care for millions of patients around the world? Want to learn more? Check out our 6-part Biosimilar Educational Series, adapted from materials provided by the Biosimilars Council. Fresenius Kabi is a member of the Biosimilars Council, a division of AAM.

Biosimilars Education Series

Myths & Facts About Biosimilars

Benefits of Biosimilars

Biosimilars: Information for Patients

At the forefront of health care innovation
Fresenius Kabi develops reliable, high-quality biosimilars for autoimmune diseases and oncology. Learn how we as a global health care company are at the forefront of health care innovation and patient care.

Play Video

Providing affordable medicines

Play Video

Fresenius Kabi: caring for life

Play Video

What biosimilars mean to me

Fresenius Kabi is a member of the Biosimilars Council

The Biosimilars Council works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products. The council educates the public and patients about the safety and effectiveness of biosimilars, focusing on access, the regulatory environment, reimbursement and legal affairs.

Useful information and resources from the Biosimilars Council:

For Patients and Caregivers

For Medical Professionals

For Payers

For Policymakers

Fresenius Kabi is a member of the Biosimilars Forum

The Biosimilars Forum is a nonprofit organization whose mission is to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines and improving health care. The founding members of the Biosimilars Forum represent the majority of companies with the most significant U.S. biosimilars development portfolios.

Useful information from the Biosimilars Forum